|
KIAA1143 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95643501399445E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21660040217375E-10 |
| Normal-vs-Stage2 |
2.03359999995101E-06 |
| Normal-vs-Stage3 |
5.34439159594058E-12 |
| Normal-vs-Stage4 |
3.7661995744287E-10 |
| Stage1-vs-Stage2 |
8.839000E-01 |
| Stage1-vs-Stage3 |
6.304100E-02 |
| Stage1-vs-Stage4 |
4.799900E-02 |
| Stage2-vs-Stage3 |
1.357420E-01 |
| Stage2-vs-Stage4 |
1.056360E-01 |
| Stage3-vs-Stage4 |
8.117200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.8544501751735E-12 |
| Normal-vs-AfricanAmerican |
1.799630E-04 |
| Normal-vs-Asian |
3.18080000005772E-07 |
| Caucasian-vs-AfricanAmerican |
9.576000E-01 |
| Caucasian-vs-Asian |
5.452200E-01 |
| AfricanAmerican-vs-Asian |
6.905400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17510001729215E-10 |
| Normal-vs-Female |
5.01076957704072E-12 |
| Male-vs-Female |
6.421600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12420000478275E-08 |
| Normal-vs-Age(41-60Yrs) |
2.30615526675138E-12 |
| Normal-vs-Age(61-80Yrs) |
5.55000490010116E-11 |
| Normal-vs-Age(81-100Yrs) |
1.017780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.359830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.602400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.384000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.675000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.763400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.139200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.483510E-02 |
| Classical-VS-Follicular |
9.278400E-03 |
| Classical-VS-Other |
4.176600E-01 |
| Classical-VS-Normal |
1.59040003389066E-09 |
| Tall-VS-Follicular |
7.323800E-01 |
| Tall-VS-Other |
8.253800E-01 |
| Tall-VS-Normal |
6.89059997949215E-09 |
| Follicular-VS-Other |
9.687400E-01 |
| Follicular-VS-Normal |
2.96399571553252E-11 |
| Other-VS-Normal |
7.044300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32238664463102E-12 |
| Normal-vs-N1 |
1.16809999450851E-08 |
| N0-vs-N1 |
5.276800E-01 |
|
|
